Taiwan

4 Vaccines Approved for Use in Taiwan

Protein Subunit

Medigen

MVC-COV1901

Approved in 3 countries
14 trials in 4 countries
Approval Source: reuters.com
RNA

Moderna

Spikevax

Approved in 86 countries
67 trials in 23 countries
Approval Source: taiwannews.com.tw
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
Approval Source: cdc.gov.tw
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Approval Source: reuters.com

7 in Clinical Trials in Taiwan

Protein Subunit

COVAXX

UB-612

7 trials in 2 countries
Protein Subunit

Medigen

MVC-COV1901

Approved in 3 countries
14 trials in 4 countries
RNA

Moderna

Spikevax

Approved in 86 countries
67 trials in 23 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Protein Subunit

Adimmune Corporation

AdimrSC-2f

3 trials in 2 countries
Protein Subunit

Medigen

MVC-COV1901(Beta)